GOOG
57
-12
MDLZ
36
-4
DNB
48
-2
KMX
52
-5
GM
80
-2
ETR
75
-2
PFE
33
5
ACN
56
2
TAP
41
-2
VRSK
77
7
EFX
77
2
COST
53
3
JWN
75
11
CCL
79
-2
ZION
69
-2
FSLR
47
-20
LEG
50
-4
ED
52
2
DD
38
-2
AMP
69
11
GOOG
57
-12
MDLZ
36
-4
DNB
48
-2
KMX
52
-5
GM
80
-2
ETR
75
-2
PFE
33
5
ACN
56
2
TAP
41
-2
VRSK
77
7
EFX
77
2
COST
53
3
JWN
75
11
CCL
79
-2
ZION
69
-2
FSLR
47
-20
LEG
50
-4
ED
52
2
DD
38
-2
AMP
69
11
Financhill
Back

Vallourec SA 10K Form

Buy
82

VLOWY
Vallourec SA

Last Price:
$3.97
Seasonality Move:
-13.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VLOWY News And Ratings

See the #1 stock for the next 7 days that we like better than VLOWY

VLOWY Financial Statistics

Sales & Book Value

Annual Sales: $4.4B
Cash Flow: $120M
Price / Cash Flow: 13.33
Annual Sales: $2.38
Price / Book: 1.62

Profitability

EPS (TTM): 0.37940
Net Income (TTM): $464M
Gross Margin: $1.3B
Return on Equity: 17.34%
Return on Assets: 7.9%

Vallourec SA Earnings Forecast

Key Vallourec SA Financial Ratios

  • The Gross Profit Margin over the past 24 years for VLOWY is 29.47%.
  • The Selling, General & Administrative Expenses for VLOWY have been equal to 7.90% of Gross Profit Margin.
  • The Research & Development expenses have been 0.80% of Revenue.
  • The Interest Expense is 6.17% of Operating Income.
  • The Net Earning history of VLOWY is 11.21% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 13 years.

Vallourec SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Energy Equipment & Services
Sector: Energy
Current Symbol: VLOWY
Website: vallourec.com

Debt

Debt-to-Equity Ratio: 0.38
Current Ratio: 2.38
Quick Ratio: 1.27

Price-to-Earnings

Trailing P/E Ratio: 9.39
Forward P/E Ratio: 0

VLOWY Technical Analysis vs Fundamental Analysis

Buy
82
Vallourec SA (VLOWY) is a Buy

Is Vallourec SA a Buy or a Sell?

  • Vallourec SA stock is rated a Buy
    The current Vallourec SA [VLOWY] share price is $3.86. The Score for VLOWY is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.